Speciality Medicines shares list at IPO price on BSE SME, gain 4% post stock market debut
Speciality Medicines' share price rose to ₹129.50, recording a 4.4% rise against the offer and listing price. The listing was in line with expectations as the grey market premium (GMP) was nil, suggesting a flattish debut for Speciality Medicines shares.
Speciality Medicines IPO Listing: Shares of Speciality Medicines, a pharma company, listed on the BSE SME platform at par with the initial public offering (IPO) price of ₹124 on Monday, March 30.
Soon after listing, Speciality Medicines' share price rose to ₹129.50, recording a 4.4% rise against the offer and listing price. The listing was in line with expectations as the grey market premium (GMP) was nil, suggesting a flattish debut for Speciality Medicines shares.
As of 10.40 am, Speciality Medicines' stock price was trading 2.42% higher at ₹127 apiece.
Speciality Medicines IPO details
The IPO of Speciality Medicines, open for bidding from March 20 to March 24, was booked 2.27 times as it garnered bids for 49,87,000 shares as against 22,00,000 shares on offer. The qualified institutional buyer (QIB) segment was booked a whopping 96.24 times, while the non-institutional investor (NII) quota received 1.88 times bids.
The individual investor portion remained undersubscribed at 0.85 times, signalling tepid interest from the retailers.
Speciality Medicines IPO was a book-built issue of ₹29 crore, consisting entirely of a fresh issue of 0.24 crore shares. Investors could apply for the SME IPO in the price band of ₹11 to ₹124 apiece in lots of 1000 shares. For a retail investor, the minimum investment requirement was ₹2,48,000 as they needed to apply for at least two lots.
The company plans to use the funds raised for setting up an R&D centre, product development for sale in the international market, funding marketing and promotional activities, funding working capital needs and for general corporate purposes.
Unistone Capital acted as the book-running lead manager, and Skyline Financial Services was the registrar of the issue.
About the company
Speciality Medicines is engaged in the business of marketing and distribution of finished formulations of specialty pharmaceutical products, comprising high-cost oral and injectable medications used in the treatment of complex and chronic medical conditions in therapeutic areas such as oncology, immunology, neurology, and rare diseases.
The company operates through two integrated business models: Manufacturing, on a contract manufacturing basis, approved finished formulations and distributing them internationally; and marketing and distribution of specialty pharmaceutical products sourced from manufacturers.
About the Author
Saloni Goel has over nine years of experience as a business journalist, with a strong track record of covering the financial markets. Over the course of her career, she has reported extensively on global and domestic equities, IPO market activity, commodities, and broader macroeconomic trends. Her reporting reflects a keen eye for detail, data-driven analysis, and the ability to spot emerging themes early.<br> At Mint, Saloni has been part of the markets team for nearly two years, where she currently works as Chief Content Producer. In this role, she plays a key part in shaping market coverage, driving editorial strategy, and ensuring timely, accurate, and insightful reporting across. She has been closely involved in breaking news coverage and in crafting stories that help decode the complex financial developments.<br> Before joining Mint, Saloni worked with some of India’s leading business newsrooms, including The Economic Times and Business Standard. Throughout her career, she has worn multiple hats—ranging from reporting and editing to contributing in-depth features and identifying new storytelling formats and market trends.<br> Her experience in fast-paced digital newsrooms has given her an edge in simplifying complex market concepts without losing analytical depth. Outside of work, Saloni enjoys reading books and spending time with her pet.
Catch all the Business News , Market News , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.